Safety
ADVERSE EVENTS, EVENTS, ADVERSE EVENT
The mean (Overall, treatment with RO5459072 at 200 mg daily (administered as 100 mg BID) over 12 weeks was well-tolerated (Overview of adverse eventsAdverse events were encoded using MedDRA version 20.0. Multiple occurrences of the same adverse event in one individual were counted only once except for within the ‘Total number of adverse events’ row, in which multiple occurrences of the same adverse event were counted separately.